Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $102.6 million.

  • Mesoblast's Total Current Liabilities rose 4011.71% to $102.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $102.6 million, marking a year-over-year increase of 4011.71%. This contributed to the annual value of $102.6 million for FY2025, which is 4011.71% up from last year.
  • According to the latest figures from Q2 2025, Mesoblast's Total Current Liabilities is $102.6 million, which was up 4011.71% from $72.8 million recorded in Q4 2024.
  • In the past 5 years, Mesoblast's Total Current Liabilities ranged from a high of $102.6 million in Q2 2025 and a low of $31.4 million during Q4 2023
  • Its 5-year average for Total Current Liabilities is $66.2 million, with a median of $56.3 million in 2021.
  • As far as peak fluctuations go, Mesoblast's Total Current Liabilities crashed by 4746.77% in 2022, and later soared by 13193.16% in 2024.
  • Over the past 5 years, Mesoblast's Total Current Liabilities (Quarter) stood at $58.0 million in 2021, then dropped by 5.83% to $54.6 million in 2022, then tumbled by 42.53% to $31.4 million in 2023, then soared by 131.93% to $72.8 million in 2024, then surged by 41.07% to $102.6 million in 2025.
  • Its last three reported values are $102.6 million in Q2 2025, $72.8 million for Q4 2024, and $73.2 million during Q2 2024.